MedPath

The effectiveness of unified transdiagnostic treatment on body dysmorphic disorder comorbid with emotional disorders

Not Applicable
Conditions
body dysmorphic disorder comorbid with emotional disorders.
Body dysmorphic disorder
F45.22
Registration Number
IRCT20231001059577N1
Lead Sponsor
niversity of Kurdistan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
34
Inclusion Criteria

Diagnosis of BDD disorder according to DSM-5
Having a minimum score of 53 in the body image concern inventory of Littleton et al
The presence of at least one emotional disorder
Age range of people from 18 to 45 years
Willing to participate in the study by signing a written consent form
The ability to speak Persian in all assessments
Not having serious mental disorders such as psychosis, bipolar type I or II
Not having suicidal thoughts
No abuse of benzodiazepines, antipsychotics, and SSRI medicines in the last 6 months

Exclusion Criteria

Need for medical intervention
Receiving psychotherapy sessions at the same time
Concerns about weight-related eating disorders
Unwillingness to continue participating at any time in the study
Absence of more than 3 sessions in treatment sessions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Score of Body Image Concern from BICI questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Body Image Concern Inventory.;Score of depression and Anxiety from DASS-21 questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: DASS-21 questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath